Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2003
08/14/2003WO2003066047A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066046A1 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
08/14/2003WO2003066044A1 New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
08/14/2003WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066033A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/14/2003WO2003066032A1 Formulations for inhalation
08/14/2003WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
08/14/2003WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066005A2 Ansamycins having improved pharmacological and biological properties
08/14/2003WO2003065988A2 A combination for treating cold and cough
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003045331A3 Formulations for oral administration of cromolyn sodium
08/14/2003WO2003037335A8 5-heteroatom-substituted pyrazoles
08/14/2003WO2003035237A3 Compounds for use as surfactants
08/14/2003WO2003013655A3 Carbonic anhydrase inhibitors
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002052036A3 Identification of modulators of dham-kinase and inflammatory diseases
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003US20030153750 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/14/2003US20030153621 Administering mixtures of 13-hydroxyoctadeca-9Z,11E-dienoic acid (13-HODE) and carriers comprising glycerides or fatty esters as controllers of endothelial growth factors
08/14/2003US20030153606 Antiproliferative agents for treating adipocyte differentiation, cancer, osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease
08/14/2003US20030153605 Enzyme inhibitors of nitric oxide synthase
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/14/2003US20030153587 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
08/14/2003US20030153578 CCR-3 receptor antagonists (I)
08/14/2003US20030153575 Tetracyclic diketopiperazine compounds as pdev inhibitors
08/14/2003US20030153569 Novel pyrazole and pyrazoline substituted compounds
08/14/2003US20030153568 Serine/threonine and tyrosine kinases inhibitors
08/14/2003US20030153566 Adenosine receptor agonist
08/14/2003US20030153558 Immunomodulators and/or inhibiting cytokine release
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153536 Compounds and methods of treating transplant rejection
08/14/2003US20030153523 Screening library of test compounds, each of which is attached to a solid support, with a dye-labeled RNA molecule to form a dye-labeled target RNA:support-attached test compound complex
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153506 Anticoagulant therapy; multicompartment kits, synergistic effect using the mixtures
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153075 TGF-beta-specific covalently closed antisense molecule
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153018 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
08/14/2003US20030152651 Herbal composition for angina pectoris, method to prepare same and uses thereof
08/14/2003US20030152626 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
08/14/2003US20030152617 Capsule, tablet with enteric, protective coatings; bioavailability
08/14/2003US20030152594 Immunology response intensifiers; administering a bacterial lysate
08/14/2003CA2483630A1 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations
08/14/2003CA2475767A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
08/14/2003CA2475329A1 Truncated aggrecanase molecules
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475093A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003CA2474974A1 Cytoprotective benzofuran derivatives
08/14/2003CA2474917A1 Granzyme b inhibitors
08/14/2003CA2474748A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003CA2474508A1 Ansamycins having improved pharmacological and biological properties
08/14/2003CA2474016A1 A combination for treating cold and cough
08/14/2003CA2474011A1 Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
08/14/2003CA2473706A1 Heterocyclic compounds having elastase-inhibitory activity and intermediates thereof
08/14/2003CA2467555A1 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl)-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-me thyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1334102A1 Bombesin receptor antagonists
08/13/2003EP1334100A1 Bombesin receptor antagonists
08/13/2003EP1334089A1 Quinoline derivatives as nk-3 and nk-2 antagonists
08/13/2003EP1334088A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
08/13/2003EP1334086A1 Phenoxyphenyl alkane sulfonates
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333833A2 Novel compounds
08/13/2003EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids
08/13/2003EP1333823A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
08/13/2003EP1333819A2 Inhalative solution formulation containing a tiotropium salt
08/13/2003EP1333809A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1222193B1 Imidazole derivatives as phosphodiesterase vii inhibitors
08/13/2003EP1220845B1 Aryl-sulfonamide substituted benzimidazol derivatives and use of said as tryptase inhibitors
08/13/2003EP1140943B1 Substituted pyrroloindoles
08/13/2003EP1135036A4 Smoking products containing antioxidants
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP1023279B8 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
08/13/2003EP0987269B1 Salts of optically active sulfoxide derivative
08/13/2003EP0923568B9 Novel benzofuran-4-carboxamides
08/13/2003EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
08/13/2003EP0814809B1 Aryl thioxanthines
08/13/2003EP0665843B1 Substituted quinuclidines as substance p antagonists
08/13/2003CN1436235A Anti-angiogenic polypeptides
08/13/2003CN1436188A 1,3,8-triaza-spiroÒÇö4,5ÒÇòdecan-4-one derivs. as neurokinin receptor antagonists
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436084A Remedies for allergic diseases and process for producing same
08/13/2003CN1436079A Imidazopyridine and imidazopyrimidine antiviral agent
08/13/2003CN1436073A Management of snoring by oral administration of dimethyl sulfone
08/13/2003CN1435248A Chinese medicine preparation for treating upper respiratory system diseases, skin infection and pile, and preparing method thereof
08/13/2003CN1435229A ÔÇ£ErbeimuÔÇØ capsule preparing process thereof
08/13/2003CN1435221A Medicine for treating mouth and gullet diseases
08/13/2003CN1435182A Cell growth regulatory factor N and preparing process thereof
08/13/2003CN1117738C Endothelin antagonists
1 ... 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 ... 878